<scp>N6</scp>‐isopentenyladenosine inhibits aerobic glycolysis in glioblastoma cells by targeting <scp>PKM2</scp> expression and activity
Cristina Pagano(Federico II University Hospital), Maurizio Bifulco(University of Naples Federico II)
Cited by 6
Related Papers
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells
|Oncotarget|2015|54
Antiglioma effects of<scp>N</scp>6‐isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor
|International Journal of Cancer|2016|34
N6-Isopentenyladenosine Enhances the Radiosensitivity of Glioblastoma Cells by Inhibiting the Homologous Recombination Repair Protein RAD51 Expression
|Frontiers in Oncology|2020|15
The isoprenoid end product N6-isopentenyladenosine reduces inflammatory response through the inhibition of the NFκB and STAT3 pathways in cystic fibrosis cells
|Inflammation Research|2017|14
N6-Isopentenyladenosine Hinders the Vasculogenic Mimicry in Human Glioblastoma Cells through Src-120 Catenin Pathway Modulation and RhoA Activity Inhibition
|International Journal of Molecular Sciences|2021|11